Skip to main content
. 2021 Feb 4;8(7):ofab063. doi: 10.1093/ofid/ofab063

Table 1.

S. pneumoniae Macrolide Resistance Rates by Setting and US Census Region

% Resistant (No. Tested)
Setting or Region No. of Facilities Blood Isolates Respiratory Isolates All Isolates
Total 329a 29.6 (1591) 47.3 (2035) 39.5 (3626)
 Inpatient 313 28.2 (1211) 45.2 (1587) 37.8 (2798)
 Ambulatory 231 33.9 (380) 54.9 (448) 45.3 (828)
Census region (states)
 West North Central (IA, KS, MN, MO, ND, NE, SD) 12 52.1 (48) 55.0 (131) 54.2 (179)
 South Atlantic (DE, DC, FL, GA, MD, NC, SC, VA, WV) 40 30.3 (145) 60.8 (199) 48.0 (344)
 East South Central (AL, KY, MS, TN) 49 38.0 (229) 55.6 (252) 47.2 (481)
 West South Central: (AR, LA, OK, TX) 71 35.6 (455) 48.5 (643) 43.2 (1098)
 East North Central: (IL, IN, MI, OH, WI) 56 29.0 (217) 49.7 (320) 41.3 (537)
 Middle Atlantic (NJ, NY, PA) 50 28.3 (191) 39.8 (236) 34.7 (427)
 Pacific (AK, CA, OR, WA) 36 13.2 (257) 25.3 (190) 18.3 (447)
 New England (CT, MA, ME, NH, RI, VT) 5 4.0 (25) 25.0 (52) 18.2 (77)
 Mountain (AZ, CO, ID, MT, NM, NV, UT, WY) 10 4.2 (24) 33.3 (12) 13.9 (36)

aFacilities could provide both inpatient and ambulatory services.